Florida Clinics: SB 1768 Opens the Door to Regenerative Medicine
Starting July 1, 2025, Florida law allows licensed physicians to offer stem cell therapies for orthopedic, pain, and wound care—if you meet compliance standards. Position your clinic at the forefront of the booming biologics market projected to reach $300B+ by 2030.
Licensed MDs and DOs can now legally offer certain unapproved stem cell therapies
Specific Applications
Treatments limited to orthopedic conditions, pain management, and wound care
Effective Date
Law goes into effect July 1, 2025 - time to prepare your practice now
Compliance Required
Strict standards must be met to avoid penalties and maximize benefits
SB 1768 Compliance Requirements Made Simple
Legal Framework
SB 1768 creates a clear pathway for Florida physicians to offer stem cell therapies, but with strict requirements. Violations can result in felony charges, making proper compliance essential for your practice.
Regenerative Research Group provides turnkey solutions to ensure your clinic meets every standard—from sourcing to documentation to patient consent.
Our comprehensive compliance program covers every aspect of SB 1768, protecting your practice while maximizing this new revenue opportunity.
Licensed Provider Administration
Therapies must be administered by a licensed MD or DO within their scope of practice
Accredited Sourcing
Materials must come from accredited facilities with full documentation and chain of custody
Patient Informed Consent
Detailed consent forms and specific FDA disclaimers required by law
Treatment Documentation
Comprehensive records must be maintained for each treatment cycle
Why This Is Your Clinic's Game-Changing Opportunity
$192B
US Biologics Market
Current market value (2024)
$300B+
Projected Growth
Expected US market by 2030
129M+
Potential Patients
Americans with applicable conditions
10%+
Annual Growth
CAGR across key sectors
For the first time, Florida clinics can legally offer these high-demand, cash-based services. This allows you to add a profitable new modality, increase revenue per visit, and differentiate your practice with cutting-edge therapies patients are actively seeking.
Patient Testimonial: Competitive Success Story
After stem cell therapy, I avoided surgery and returned to training faster than expected. It's been a game-changer for my competitive career.
Kris, Competitive Heavyweight Athlete
Kris represents the real-world impact our regenerative therapies deliver. His experience demonstrates the powerful recovery advantages now available to your patients.
Superior Sourcing & Processing for Maximum Viability
Industry-Leading Results
Higher patient satisfaction and clinical outcomes
Rapid Processing
Materials preserved within hours of collection
Superior Cell Viability
Proprietary methods ensure high post-thaw cellular activity
100% Chain of Custody
Complete tracking from donation to delivery
Direct OB/GYN Network
No third-party tissue banks means better verification
Our proprietary processing methods and direct sourcing network ensure you receive materials with maximum therapeutic potential, meeting all compliance requirements while delivering superior patient outcomes.
Built-In Compliance Tools Protect Your Practice
Patient Consent Forms
Pre-built, legally-reviewed informed consent documents that satisfy all SB 1768 requirements
In-Clinic Signage
Required 8.5"x11" notices with 40-point font disclaimers ready for display
Marketing Disclaimers
Compliant language for all advertising and promotional materials
Legal Protection
Documentation designed to protect against regulatory liability
Navigating the regulatory landscape between federal prohibitions and Florida's new law requires precision. Our plug-and-play compliance tools eliminate guesswork and minimize legal risk for your practice.
The RRG Difference: Direct Sourcing, Superior Quality
Exclusive OB/GYN Network
Direct relationships with verified providers, not anonymous tissue banks
Comprehensive Screening
Multi-generational health history and lifestyle verification
Complete paperwork trail for regulatory protection
Unlike competitors who rely on third-party tissue banks, our direct sourcing model gives you unparalleled insight into material origins, superior quality control, and comprehensive documentation that exceeds compliance requirements.
Turnkey Launch Solution for Your Regenerative Practice
Clinic Assessment
Compliance audit and readiness evaluation
System Implementation
Workflow templates and documentation setup
Staff Training
Front desk to provider education programs
Patient Acquisition
Complete marketing funnel and sales support
We don't just deliver products—we provide complete success systems. From initial compliance preparation through ongoing marketing support, our team walks with you every step of the way to ensure a successful and profitable regenerative medicine program.
Proven Results With Florida-Ready Compliance
Clinical Success
One of our partner clinic generated over $72,000 in additional revenue within the first 30 days of implementing our regenerative medicine programs, all while maintaining 100% compliance with standards identical to SB 1768.
Patient Testimonials
Competitive heavyweight athlete Kris avoided surgery and returned to training faster after stem cell therapy. Many other patients have been supported their recovery aat the cellular level.
Compliance Excellence
Our comprehensive training programs ensure your entire team understands the regulatory requirements and clinical protocols necessary for successful, compliant implementation of regenerative therapies under Florida's new legislation.
We've already helped clinics nationwide implement regenerative programs that meet or exceed Florida's upcoming standards. Our proven systems deliver both clinical excellence and financial results.
Ready to Lead Florida's Regenerative Medicine Revolution?
What happens during my free readiness consultation?
During your complimentary consultation, we'll assess your clinic's current setup, discuss your goals for implementing regenerative therapies, and provide a customized roadmap for compliance with SB 1768. You'll receive actionable insights regardless of whether you partner with us.
When can we begin offering these services?
SB 1768 takes effect July 1, 2025. However, preparation should begin now to ensure your clinic is fully compliant on day one. Our pre-launch program helps you build systems, train staff, and develop marketing strategies so you're ready to capture this opportunity immediately.
How does your program differ from others?
Unlike competitors who simply provide products, we offer a complete launch solution including compliance documentation, direct-sourced materials with superior viability, staff training, and ongoing marketing support. Our unique direct sourcing network eliminates third-party tissue banks for better quality control and documentation.